A new initiative from ConcertAI, Engaging Research to Achieve Cancer Care Equity (ERACE), is directed by experts from academic, pharmaceutical, and healthcare organizations to leverage real-world data to reduce cancer care disparities.

ERACE advisory board member Erica Warner, ScD MPH spoke with Jessica Kent of HealthITAnalytics about the impact that we hope to see ERACE have on cancer patient outcomes, starting with equity in clinical trials, and the role that RWD plays in making this happen.